237 results found for “Online PEGACPLSA88V1 Bootcamps 💺 New PEGACPLSA88V1 Test Dumps 🦡 PEGACPLSA88V1 Latest Examprep 🧘 Download ⏩ PEGACPLSA88V1 ⏪ for free by simply entering ➽ www.pdfvce.com 🢪 website 🐠Lab PEGACPLSA88V1 Questions”

Small Molecule Characterization

https://carterra-bio.com/applications/small-molecule-characterization/

…Library (DEL) Compounds Confidently determine detailed kinetic profiles (ka & kd) and affinity (KD) for DNA-tagged fragments, compounds, and targeted protein degraders (TPDs). Gold standard SPR technology affords real-time, label-free

2023 Carterra Symposia

https://carterra-bio.com/news/2023-carterra-symposia/

Unlocking High-Throughput Biology and Drug Discovery – View Speaker Presentations Industry and academic scientists presented new paradigms in discovery, applications and workflows including HT-SPR. Topics included: New methods in antibody…

Effectively Screen Biotherapeutic Targets Using Carterra’s Powerful Software Suite

https://carterra-bio.com/resources/effectively-screen-biotherapeutic-targets-using-a-dynamic-ht-spr-platform/

https://www.youtube.com/watch?v=1lxPXirpPpw Posted by Noah T. Ditto Summary: The Carterra LSA is making screening for large numbers of biotherapeutic targets a more effective and revealing process by using high-throughput Surface Plasmon…

Assessing the Binding Properties of the Anti-PD-1 Antibody Landscape Using Label-free Biosensors – March 5, 2020

https://carterra-bio.com/resources/assessing-the-binding-properties-of-the-anti-pd-1-antibody-landscape-using-label-free-biosensors/

…of our methods. The LSA instrument was also used to perform epitope binning and ligand competition studies which revealed over ten unique competitive binding profiles within this group of mAbs….

eBook: Streamlining Library-to-Lead for your Antibody Therapeutics

https://carterra-bio.com/resources/gen-ebook-streamlining-library-to-lead-for-your-antibody-therapeutics/

…in parallel with minimal sample consumption, making it significantly faster and more efficient than other methods. To learn more about Carterra’s high throughput SPR capabilities, visit us online at: www.carterra-bio.com

IgG Fc Variant Cross-reactivity Between Human and Rhesus Macaque FcγRs – February 3, 2017

https://carterra-bio.com/resources/igg-fc-variant-cross-reactivity-between-human-and-rhesus-macaque-fc%ce%b3rs/

MAbs. 2017 Feb 03; doi: 10.1080/19420862.2016.1274845. Boesch AW, Miles AR, Chan YN, Osei-Owusu NY, Ackerman ME. Abstract Non-human primate (NHP) studies are often an essential component of antibody development efforts…

Carterra LSA

https://carterra-bio.com/lsa/

Carterra LSA for Antibody Discovery & Development Disruptive Technology for mAb Screening and Characterization Understanding a mAb’s mechanism of action (MOA) is fundamental to the discovery of superior (safe and…

A Natively Paired Antibody Library Yields Drug Leads with Higher Sensitivity and Specificity Than a Randomly Paired Antibody Library – February 1, 2018

https://carterra-bio.com/resources/a-natively-paired-antibody-library-yields-drug-leads-with-higher-sensitivity-and-specificity-than-a-randomly-paired-antibody-library/

…therapeutic antibody candidates in mouse B cell repertoires. In this study, we compare a deep sequencing and scFv display method that retains native heavy and light chain pairing with a…

Genovac Acquires the Carterra LSA Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services

https://carterra-bio.com/news/genovac-acquires-the-carterra-lsa-instrument-to-enable-state-of-the-art-antibody-screening-and-characterization-services/

…said Tim Germann, Chief Commercial Officer at Carterra. “We’re particularly pleased that Genovac has received the 100th LSA platform. Like Carterra, Genovac is completely committed to serving their clients with…

2019 Carterra Symposia

https://carterra-bio.com/news/2019-carterra-symposia/

…discovery screening process. This new process, combining with functional analysis, enables a robust workflow for lead identification. Results from an ongoing project executing this new workflow is used to demonstrate…